DarioHealth Corp Net Worth
DarioHealth Corp Net Worth Breakdown | DRIO |
DarioHealth Corp Net Worth Analysis
DarioHealth Corp's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including DarioHealth Corp's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of DarioHealth Corp's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform DarioHealth Corp's net worth analysis. One common approach is to calculate DarioHealth Corp's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares DarioHealth Corp's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing DarioHealth Corp's net worth. This approach calculates the present value of DarioHealth Corp's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of DarioHealth Corp's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate DarioHealth Corp's net worth. This involves comparing DarioHealth Corp's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into DarioHealth Corp's net worth relative to its peers.
Enterprise Value |
|
To determine if DarioHealth Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding DarioHealth Corp's net worth research are outlined below:
| DarioHealth Corp generated a negative expected return over the last 90 days | |
| DarioHealth Corp has high historical volatility and very poor performance | |
| DarioHealth Corp has some characteristics of a very speculative penny stock | |
| DarioHealth Corp has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 20.35 M. Net Loss for the year was (59.43 M) with profit before overhead, payroll, taxes, and interest of 14.01 M. | |
| DarioHealth Corp currently holds about 67.95 M in cash with (30.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| DarioHealth Corp has a poor financial position based on the latest SEC disclosures | |
| Roughly 18.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Dario Signs Four New Employer Contracts Across Full Product Suite |
DarioHealth Corp Quarterly Good Will |
|
DarioHealth Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in DarioHealth Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to DarioHealth Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know DarioHealth Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as DarioHealth Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DarioHealth Corp backward and forwards among themselves. DarioHealth Corp's institutional investor refers to the entity that pools money to purchase DarioHealth Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-09-30 | 87.7 K | Ubs Group Ag | 2024-06-30 | 77.3 K | State Street Corp | 2024-06-30 | 75 K | Northern Trust Corp | 2024-09-30 | 69.5 K | Citadel Advisors Llc | 2024-09-30 | 66.4 K | Susquehanna International Group, Llp | 2024-06-30 | 38.4 K | Xtx Topco Ltd | 2024-09-30 | 29.5 K | Clarity Capital Partners Llc | 2024-09-30 | 28.2 K | Bank Of Montreal | 2024-06-30 | 25.5 K | Nantahala Capital Management, Llc | 2024-09-30 | 2.5 M | Appian Way Asset Management | 2024-09-30 | 1.4 M |
Follow DarioHealth Corp's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.56 M.Market Cap |
|
Project DarioHealth Corp's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.20) | (1.26) | |
| Return On Capital Employed | (0.67) | (0.70) | |
| Return On Assets | (0.62) | (0.65) | |
| Return On Equity | (1.02) | (0.97) |
When accessing DarioHealth Corp's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures DarioHealth Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of DarioHealth Corp's profitability and make more informed investment decisions.
Evaluate DarioHealth Corp's management efficiency
DarioHealth Corp has return on total asset (ROA) of (0.3474) % which means that it has lost $0.3474 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7491) %, meaning that it created substantial loss on money invested by shareholders. DarioHealth Corp's management efficiency ratios could be used to measure how well DarioHealth Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -1.26. In addition to that, Return On Capital Employed is likely to drop to -0.7. At this time, DarioHealth Corp's Intangibles To Total Assets are very stable compared to the past year. As of the 28th of November 2024, Debt To Assets is likely to grow to 0.31, while Other Current Assets are likely to drop about 1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.05 | 2.15 | |
| Tangible Book Value Per Share | 0.39 | 0.41 | |
| Enterprise Value Over EBITDA | (0.76) | (0.80) | |
| Price Book Value Ratio | 0.84 | 0.71 | |
| Enterprise Value Multiple | (0.76) | (0.80) | |
| Price Fair Value | 0.84 | 0.71 | |
| Enterprise Value | 41.5 M | 27.6 M |
The operational strategies employed by DarioHealth Corp management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Enterprise Value Revenue 1.645 | Revenue 23.1 M | Quarterly Revenue Growth 1.11 | Revenue Per Share 0.631 | Return On Equity (0.75) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DarioHealth Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on DarioHealth Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DarioHealth Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DarioHealth Corp time-series forecasting models is one of many DarioHealth Corp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DarioHealth Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
DarioHealth Corp Earnings per Share Projection vs Actual
DarioHealth Corp Corporate Management
| Tomer BenKiki | Chief Officer | Profile | |
| Josh Fischer | Senior Compliance | Profile | |
| Dov Oppenheim | CoFounder Chief | Profile | |
| Brian Harrigan | Senior Sales | Profile | |
| Richard Anderson | President | Profile | |
| Claudia Levi | Content Manager | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.93) | Revenue Per Share 0.631 | Quarterly Revenue Growth 1.11 | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.